 PHILADELPHIA and VANCOUVER, British Columbia, Sept. 28, 2022 GLOBE NEWSWIRE -- BriaCell Therapeutics Corp. Nasdaq: BCTX, BCTXW TSX: BCT BriaCell or the Company, a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, is pleased to announce that its lead product candidate, Bria-IMTTM, will be featured in three posters during the 2022 San Antonio Breast Cancer Symposium taking place December 6-10, 2022 at the Henry B. Gonzalez Convention Center in San Antonio, Texas. 